Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System

Yeramaneni et al., Gastroenterology, doi:10.1053/j.gastro.2020.10.011, Feb 2021
Retrospective 7,158 hospitalized COVID-19 patients in the USA analyzing famotidine treatment, showing no significant difference in mortality with associated azithromycin treatment.
Standard of Care (SOC) for COVID-19 in the study country, the USA, is very poor with very low average efficacy for approved treatments1. Only expensive, high-profit treatments were approved for early treatment. Low-cost treatments were excluded, reducing the probability of early treatment due to access and cost barriers, and eliminating complementary and synergistic benefits seen with many low-cost treatments.
Study covers remdesivir and famotidine.
OutcomeImprovementEffect · pTreatmentControl
risk of death 7.0% lower · OR 0.93 · p = 0.84 7.0% lowerOR 0.93p = 0.84 4,003 3,155 treatment 4,003, control 3,155adjusted per studyRR approximated with ORmultivariableday 30

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates.

Yeramaneni et al., 28 Feb 2021, retrospective, USA, peer-reviewed, 6 authors, study period 11 February, 2020 - 8 May, 2020.
$0 $500 $1,000+ Efficacy vs. cost for COVID-19 treatment protocols c19early.org November 2026 USA Angola Colombia Kenya Mozambique Myanmar South Africa Peru Philippines Vietnam Japan Argentina Nepal Iran Bangladesh Ethiopia Ghana Germany Mexico South Korea United Kingdom Saudi Arabia Algeria Morocco Yemen Poland Uzbekistan India China Venezuela DR Congo Madagascar Thailand Uganda Egypt Nigeria Taiwan Fiji Zambia Bosnia-Herzegovina Jordan Georgia Switzerland Dominican Republic Bolivia Côte d'Ivoire Eritrea Togo Bulgaria Greece Slovakia Iceland New Zealand Trinidad and Tobago Mongolia Czechia Belarus Israel Haiti North Macedonia Hong Kong Qatar Panama Serbia USA favored high-profit treatments.The average efficacy of treatments was very low.High-cost protocols reduce early treatment, andforgo complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
$0 $500 $1,000+ Efficacy vs. cost for COVID-19treatment protocols worldwide c19early.org November 2026 USA Angola Colombia Kenya Mozambique Myanmar South Africa Peru Philippines Vietnam Japan Argentina Nepal Iran Bangladesh Ethiopia Ghana Germany Mexico South Korea United Kingdom Saudi Arabia Algeria Morocco Yemen Poland Uzbekistan India China Venezuela DR Congo Madagascar Thailand Uganda Egypt Taiwan Fiji Zambia Jordan Georgia Switzerland Dominican Rep. Bolivia Côte d'Ivoire Eritrea Togo Sri Lanka Bulgaria Greece Slovakia New Zealand Trinidad and Tobago Mongolia Czechia Belarus Israel North Macedonia Hong Kong Qatar Panama Serbia USA favored high-profit treatments.The average efficacy was very low.High-cost protocols reduce early treatment,and forgo complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
DOI record: { "DOI": "10.1053/j.gastro.2020.10.011", "ISSN": [ "0016-5085" ], "URL": "http://dx.doi.org/10.1053/j.gastro.2020.10.011", "alternative-id": [ "S0016508520352495" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System" }, { "label": "Journal Title", "name": "journaltitle", "value": "Gastroenterology" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1053/j.gastro.2020.10.011" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 by the AGA Institute" } ], "author": [ { "ORCID": "http://orcid.org/0000-0002-1411-2359", "affiliation": [], "authenticated-orcid": false, "family": "Yeramaneni", "given": "Samrat", "sequence": "first" }, { "affiliation": [], "family": "Doshi", "given": "Pratik", "sequence": "additional" }, { "affiliation": [], "family": "Sands", "given": "Kenneth", "sequence": "additional" }, { "affiliation": [], "family": "Cooper", "given": "Mandelin", "sequence": "additional" }, { "affiliation": [], "family": "Kurbegov", "given": "Dax", "sequence": "additional" }, { "affiliation": [], "family": "Fromell", "given": "Gregg", "sequence": "additional" } ], "container-title": [ "Gastroenterology" ], "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "gastrojournal.org", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 10, 12 ] ], "date-time": "2020-10-12T05:38:45Z", "timestamp": 1602481125000 }, "deposited": { "date-parts": [ [ 2021, 3, 20 ] ], "date-time": "2021-03-20T07:51:40Z", "timestamp": 1616226700000 }, "funder": [ { "DOI": "10.13039/100016646", "doi-asserted-by": "publisher", "name": "HCA Healthcare" } ], "indexed": { "date-parts": [ [ 2021, 12, 23 ] ], "date-time": "2021-12-23T22:27:20Z", "timestamp": 1640298440528 }, "is-referenced-by-count": 17, "issn-type": [ { "type": "print", "value": "0016-5085" } ], "issue": "3", "issued": { "date-parts": [ [ 2021, 2 ] ] }, "journal-issue": { "issue": "3", "published-print": { "date-parts": [ [ 2021, 2 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 2, 1 ] ], "date-time": "2021-02-01T00:00:00Z", "timestamp": 1612137600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0016508520352495?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0016508520352495?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "919-921.e3", "prefix": "10.1053", "published": { "date-parts": [ [ 2021, 2 ] ] }, "published-print": { "date-parts": [ [ 2021, 2 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1053/j.gastro.2020.05.053", "author": "Freedberg", "doi-asserted-by": "crossref", "first-page": "1129", "journal-title": "Gastroenterology", "key": "10.1053/j.gastro.2020.10.011_bib1", "volume": "159", "year": "2020" }, { "DOI": "10.14309/ajg.0000000000000832", "author": "Mather", "doi-asserted-by": "crossref", "first-page": "1617", "journal-title": "Am J Gastroenterol", "key": "10.1053/j.gastro.2020.10.011_bib2", "volume": "115", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "1054", "journal-title": "Lancet", "key": "10.1053/j.gastro.2020.10.011_bib3", "volume": "395", "year": "2020" }, { "DOI": "10.2196/19199", "author": "Rogosnitzky", "doi-asserted-by": "crossref", "journal-title": "JMIR Public Health Surveill", "key": "10.1053/j.gastro.2020.10.011_bib4", "volume": "6", "year": "2020" }, { "DOI": "10.1093/pan/mpr013", "author": "Iacus", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Political Analysis", "key": "10.1053/j.gastro.2020.10.011_bib5", "volume": "20", "year": "2012" }, { "DOI": "10.1016/S0140-6736(20)31022-9", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "1569", "journal-title": "Lancet", "key": "10.1053/j.gastro.2020.10.011_bib6", "volume": "395", "year": "2020" }, { "journal-title": "N Engl J Med", "key": "10.1053/j.gastro.2020.10.011_bib7", "year": "2020" } ], "reference-count": 7, "references-count": 7, "relation": {}, "score": 1, "short-container-title": [ "Gastroenterology" ], "short-title": [], "source": "Crossref", "subject": [ "Gastroenterology", "Hepatology" ], "subtitle": [], "title": [ "Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System" ], "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "160" }
Late treatment
is less effective